Connect with us

International

Divergence Continues to Underpin the Greenback

Overview: The divergence reflected in the flash PMI
readings seen yesterday underpinned the dollar, which is firmer in mostly quiet
turnover. The initial…

Published

on

Overview: The divergence reflected in the flash PMI readings seen yesterday underpinned the dollar, which is firmer in mostly quiet turnover. The initial Australian dollar gains scored in response to the slightly less decline in Q3 CPI have been unwound. The greenback also remains within striking distance of JPY150 where there are still some large options and some apprehension over possible BOJ intervention. Hungary's larger than expected rate cut yesterday keeps the forint under pressure today, but most emerging market currencies are softer. The Canadian dollar is near the month's low ahead of the Bank of Canada meeting. It is widely expected to leave the policy rate steady at 5.0%. 

China's stimulative measures helped lift mainland shares and those that trade in Hong Kong, but the early gains were not sustained. Among the other large markets in the region, Japan and Taiwan also rose. Europe's Stoxx 600 snapped a five-day losing streak yesterday, but it is giving back those gains today. Mixed US earnings after the close yesterday has weighed on the index futures, pointing to a lower open. Benchmark 10-year yields are firmer, 2-4 bp in Europe and the US. The 10-year US Treasury yield is near 4.86%. Gold is consolidating in a narrow range (~$1968.50-$1977). The stronger dollar and firmer yields would be expected to be a drag, but geopolitics maybe lending support. December WTI is stabilizing after a three-day drop that took it down 5%. It is holding above $83, which it briefly traded below yesterday but is struggling to push back through $84.

Asia Pacific

Despite obvious differences and wariness of each other, Japan and China are dealing with similar macro challenges, including shrinking populations. Both are leaning against the weakness of their respective currencies, which largely reflect the broad strength of the US dollar and monetary policy divergence. China is still easing monetary policy. Japan has lifted the cap on the 10-year yield (in December to 0.50% and to 1.0% in July), and reports suggest further adjustment this year is possible. However, at the same time, the BOJ is continuing to buy bonds, both scheduled and unscheduled operations. It also continues to make long-dated loans to banks at attractive rates, with the logic being they will use the loans to buy government bonds. Its balance sheet is expanding. 

The Kishida government is preparing a supplemental budget that will likely include one-year temporary income tax cuts, while extending subsidies for electricity, gasoline, and household gas to March or April 2024. Yesterday, China's National People's Congress standing committee authorized a larger budget deficit this year. It would reach 3.8% of GDP from 3% set in March. This includes additional bond issuance of CNY1 trillion (~$137 bln) this quarter to support construction and disaster relief. China rarely adjusts its budget in the middle of the year and does so typically in crises. The announcement indicated that half the new funds will be used this year. Beijing also recently announced a CNY1 trillion facility to allow regional government to swap high-interest rate off-balance borrowing for lower-interest rate bonds. At the same time, the standing committee endorsed the front-loading of next year's local bond quota. China uses a range of formal and informal mechanisms to counter the pressure on the yuan. Japanese officials have expressed concern about the yen's weakness, and used words that warned the market of the elevated threat of intervention. The BOJ's unscheduled bond purchases appear to momentarily support the yen even though it caps yields. 

Australia reported Q3 inflation did not slow as much as expected. It slowed to 5.4% from 6.0% in Q2. The 1.2% increase in the quarter means that Australia CPI is rising at about a 4.5% annualized rate this year through September. The underlying measures (weighted median and trimmed mean) rose by 1.2% and 1.3%, respectively in Q3, which brings the year-over-year pace to 5.2%. Housing and transportation, which seems like the impact of higher rates and energy prices, were the main culprits. Prices pressures are moderating, and the economy is slowing. Recall that Australian lost full-time jobs in September for the second time in three months. The flash composite October PMI crashed, falling by the most (4.2 index points) and to the lowest (47.3) since January 2022. The market's response seems exaggerated. The futures market showed a sharp increase in expectations that the central bank will hike rates when it meets again on November 7. The odds roughly doubled to around 54%. Australia's two-year yield jumped 12 bp to ~4.33%. 

The dollar recovered from the session low set in Europe yesterday near JPY149.30 and returned to the session high in late North American activity, slightly above JPY149.90. For the eighth time this month, the dollar traded below the 20-day moving average but has not closed below it since the end of July. There still appears to be large optionality at JPY150 through the end of the month, including for $1 bln tomorrow and almost $3 bln Friday. It is in an exceptionally narrow range of about 15 pips above JPY149.80. The Australian dollar was driven almost half-of-a-cent higher to $0.6400 in response to the firmer than expected CPI but stalled. It has steadily retreated and recorded session lows in the Europe near $0.6330. A break, and especially, a close below yesterday's low ($0.6330) would be a particularly bearish development. There are options at $0.6300 for around A$650 mln that expire today and a set ahead of it for A$420 mln at $0.6325. China's CSI 300 gapped higher but spent the session trying to fill the gap and settled on its lows, with the gap unfilled. The dollar, which had traded down to CNY7.2980 yesterday, a nine-day low settled firmly yesterday, and follow-through buying today lifted it to CNY7.3170. If it closes here, it would be the highest settlement since September 8 when the high was recorded near CNY7.35. The PBOC set the dollar's reference rate at CNY7.1785, slightly lower than yesterday. The median forecast in Bloomberg's survey was CNY7.3167, the highest in four sessions.

Europe

The eurozone reported money supply figures today ahead of the ECB meeting tomorrow. M3 growth peaked in 2007 at 12.6% and peaked in January 2021 there as well. However, M3 slowed in 2008-2009 and went negative in late 2009-2010 (-0.4% February 2010). Money supply growth is imploding more now. It shrank by 0.4% in July, -1.3% in August, and -1.2% in September. There was a small increase in loans. The swaps market sees practically no chance that the ECB changes policy tomorrow. It sees the next move as cut and now has around 95% of it discounted for June 2024. Separately, Germany's IFO survey stabilized. The current assessment ticked up to 89.2 from 88.7 and expectations edged up to 84.7 from 83.1. The overall business climate measure rose to 86.9 from 85.8. It is the first increase since April. Yesterday's flash PMI less optimistic.

In a true Turn-Around Tuesday, the euro gave up Monday's gains. The euro stalled in front of $1.07, its best level this month. Its gains were pared after the disappointing European PMI and then again after the US stronger than expected PMI. The single currency did not find much support until around $1.0580. We had suggested a break of the $1.0600-20 would be disappointing. The euro fell to almost $1.0565 in the European morning and now a break of the $1.0530-50 warns that three-legged correction since the year's low was set on October 3 (~$1.0450) is over. Sterling's upside correction since the seven-month low on October 4 (~$1.2035) has been flatter than the euro, the price action was just as poor. It returned to almost Monday's low (~$1.2155 vs. $1.2145) yesterday and has been sold further today. The break of $1.2135 signals a retest of last week's low near $1.2090. There are two chunky set of sterling options that expire today of particular interest. There are about GBP550 mln at $1.2125 and around GBP845 mln at $1.2100. The low set in the European morning is slightly below $1.2115. 

America

In contrast to Japan and the eurozone, which saw the preliminary October PMI soften, the US improved. The manufacturing PMI edged up to 50.0 from 49.8. The median forecast in Bloomberg's survey was for a small decline. Similarly, the service PMI rose to 50.9 from 50.1. The composite rose to 51.0 (from 50.2). It has not been below the 50 boom/bust level since January after spending H2 22 below it. The US report new homes today, and a small rise in expected after the sharp 8.7% drop in August. However, the focus is on tomorrow's Q3 GDP. The Atlanta Fed's GDP tracker will be updated later today, and it stood at 5.4% as of October 18. The median forecast in Bloomberg's survey is for 4.5% Q3 GDP, driven by a 4% rise in consumption from 0.8% in Q2. The GDP figure is unlikely to shift the conviction that the Fed is on hold next week. Meanwhile, looking further down field, a week from Friday is the October employment report. Before the 336k surge in jobs in September, the three-month average was slightly below 190k. The early call is for about 185k increase this month.

The Bank of Canada meets today. It has been on hold since a 25 bp hike was delivered in July that brought the overnight target rate to 5.0%. With September inflation lower than expected, including the underling core measures, there is little pressure on the Bank of Canada to move. The 0.2% contraction in Q2 GDP likely overstates the weakness of the economy. It is expected to grow slowly in Q3 and the following two quarters. The swaps market shows a little more than a 5% chance of hike today and a little less than an 80% chance it stands pat at the last meeting of the year on December 6. 

The US dollar traded on both sides of Monday's trading range yesterday and closed just below its high. Still, it was the strongest close for the greenback since October 4. While the Canadian dollar did not fall as much as the euro or sterling yesterday, it was the weakest among the dollar-bloc. The US dollar reached its highest level since March earlier this month near CAD1.3785 and is approaching it today ahead of the Bank of Canada meeting. It reached almost CAD1.3780 in the European morning. There are roughly $300 mln in options that expire at CAD1.3755 today. There are also options for about $685 mln at CAD1.3800 that expire tomorrow. While the Canadian dollar weakness may not help efforts to restrain price pressures, the Bank of Canada is unlikely to make much of it. Year-to-date, it is off 1.6%, which means it is holding up better than most currencies. The US dollar was confined to Monday's range yesterday against the Mexican peso (~MXN18.0775-MXN18.3750). It is trading quietly so far today between MXN18.2370 and MXN18.3365. The greenback must overcome the recent highs and push above MXN18.50 to signal the next leg up. Barring that look for consolidation above MXN18.00. 

 

Disclaimer

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

Trending